首页> 外文期刊>ChemMedChem >Integrated Synthetic, Pharmacological, and Computational Investigation of cIs-2-(3,5-Dichlorophenylcarbamoyl)-cyclohexanecarboxylic Acid Enantiomers As Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 4
【24h】

Integrated Synthetic, Pharmacological, and Computational Investigation of cIs-2-(3,5-Dichlorophenylcarbamoyl)-cyclohexanecarboxylic Acid Enantiomers As Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 4

机译:cIs-2-(3,5-二氯苯基氨基甲酰基)-环己烷羧酸对映异构体作为代谢型谷氨酸受体亚型4的正构构调节剂的综合合成,药理和计算研究

获取原文
获取原文并翻译 | 示例
           

摘要

2-(3,5-Dichlorophenyicarbamoyl)cyclohexanecarboxylic acid (1) is a potent and selective positive ailosteric modulator of me-tabotropic giutamate receptor subtype 4 (mGluR4). The activity of 1 was reported to reside in the cis diastereomer with equal potency between its enantiomeric forms (Niswender etal., Mol. Pharmacol. 2008, 74, 1345-1358). In the present study, the asymmetric synthesis of each of the cis enantiomers was performed, and their activities were compared with that of the racemic trans, in our assays, the cis enantiomers differ in potency, with one of them (1R,2S) higher and the other (15,2R) lower than the racemic trans. High-level quantum chemical calculations were carried out to characterize the structures of minimum energy in all-isomer conformational space as well as particular intermediates between conformational transitions. Computational analysis identified structural features of 1 that can play a role in mGluR4 functionality and establish the basis for subsequent work, in which molecular chirality constructed on conformations derived from those found for the active (1R,2S)enantiomer can provide new ideas for drug discovery. Comparison between experimental and theoretical circular di-chroism spectra confirmed both the absolute configuration of the (1R,2S) compound and its calculated most stable conformation, thereby supporting experimental and theoretical work.
机译:2-(3,5-二氯苯甲酰氨基甲酰基)环己烷羧酸(1)是促代谢型谷氨酸受体亚型4(mGluR4)的有效且选择性的正性欧氏调节剂。据报道1的活性存在于顺式非对映异构体中,其对映体形式之间具有相等的效力(Niswender等,Mol.Pharmacol.2008,74,1345-1358)。在本研究中,进行了每个顺式对映体的不对称合成,并将它们的活性与外消旋体的活性进行了比较,在我们的测定中,顺式对映体的效价有所不同,其中一个(1R,2S)更高另一个(15,2R)低于外消旋反式。进行了高级量子化学计算,以表征全异构体构象空间中的最小能量结构以及构象转变之间的特定中间体。计算分析确定了可以在mGluR4功能中起作用的1的结构特征,并为后续工作奠定了基础,其中基于从活性(1R,2S)对映异构体发现的构象构造的分子手性可以为药物发现提供新思路。实验和理论圆二色性光谱的比较证实了(1R,2S)化合物的绝对构型及其计算的最稳定构象,从而为实验和理论工作提供了支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号